Sana Biotechnology SANA
NASDAQ SANA
$2.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Selling, General & Administrative (2020 - 2026)

Updated

Sana Biotechnology (SANA) recorded Selling, General & Administrative of $10.78 million in Q2 2026, up 4.2% from $10.34 million a year earlier but down 6.0% from the prior quarter.

Analysis

Sana Biotechnology (SANA) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a TTM basis, Sana Biotechnology's Selling, General & Administrative came in at $44.71 million as of Jun 30, 2026, down 15.9% year-over-year; for FY2025, it came in at $44.3 million, down 30.8% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $64.04 million in FY2024 (-12.6%), $73.3 million in FY2023 (+2.4%), $71.56 million in FY2022 (+42.0%) and $50.41 million in FY2021 (+78.3%).
  • Quarterly Selling, General & Administrative has ranged from $10.29 million in Q3 2025 to $23.32 million in Q4 2022 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative rose in 1 of the last eight quarters, with an average decline of 20.3%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 89.2% in Q3 2021, against a decline of 37.1% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $11.46 million (Q1 2026), $12.19 million (Q4 2025) and $10.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Sana Biotechnology 864.99 Mn 864.99 Mn - 10.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.78 Mn
Mar 31, 2026 11.46 Mn
Dec 31, 2025 12.19 Mn
Sep 30, 2025 10.29 Mn
Jun 30, 2025 10.34 Mn
Mar 31, 2025 11.48 Mn
Dec 31, 2024 17.28 Mn
Sep 30, 2024 14.05 Mn
Jun 30, 2024 16.44 Mn
Mar 31, 2024 16.27 Mn
Dec 31, 2023 20.78 Mn
Sep 30, 2023 19.18 Mn
Jun 30, 2023 16.57 Mn
Mar 31, 2023 16.77 Mn
Dec 31, 2022 23.32 Mn
Sep 30, 2022 15.51 Mn
Jun 30, 2022 18.29 Mn
Mar 31, 2022 14.43 Mn
Dec 31, 2021 12.68 Mn
Sep 30, 2021 13.43 Mn
API Access

Sana Biotechnology Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SANA&period=max&api_key=YOUR_API_KEY